Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA6 | P23280 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | BAD | Q92934 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 3/20 | 0.34 |
| ▸ | DRD1 | P21728 | 3/20 | 0.34 |
| ▸ | DRD5 | P21918 | 3/20 | 0.34 |
| ▸ | DRD3 | P35462 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | HPN | P05981 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9463238 | 0.80 | PNMT (0.50) | PNMTHSP90AA1CA1CA2CA4 | |
| SCHEMBL382855 | 0.78 | PNMT (0.56) | PNMTCA1CA2CA4CA6 | |
| SCHEMBL28631569 | 0.78 | DRD2 (0.41) | PNMTCA1CA2CA4CA6 | |
| SCHEMBL20590538 | 0.71 | PNMT (0.49) | PNMTCA1CA2CA4CA6 | |
| SCHEMBL58474 | 0.71 | PNMT (0.58) | PNMTCA1CA2CA4CA6 | |
| SCHEMBL29034014 | 0.70 | CA2 (0.55) | CA1CA2CA4CA6NPC1 | |
| SCHEMBL6905745 | 0.70 | CA1 (0.36) | CA1CA2CA4CA6ALDH1A1 | |
| SCHEMBL442712 | 0.69 | PNMT (0.46) | PNMTCA1CA2CA4CA6 | |
| SCHEMBL31623885 | 0.69 | PNMT (0.46) | PNMTCA1CA2CA4CA6 | |
| SCHEMBL21295469 | 0.69 | PNMT (0.50) | PNMTCA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4728019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Sable Rubber IP Pty Limited (AU) | 2026-04-22 | — | — | EP | disclosed |
| EP-4642472-A1 | PLANT HYDROETHANOLIC EXTRACTS | O SIGMA CELL AND GENETIC LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4642471-A1 | PLANT HYDROETHANOLIC EXTRACTS AND USES THEREOF | IMMUNE & GENETICS PROTOCOLS LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12371642-B2 | Benefit agent containing delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| WO-2024257019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Molectra Rubber IP Pty Ltd (AU) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024141931-A1 | PLANT HYDROETHANOLIC EXTRACTS | O SIGMA CELL AND GENETIC LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141930-A1 | PLANT HYDROETHANOLIC EXTRACTS AND USES THEREOF | IMMUNE & GENETICS PROTOCOLS LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240041725-A1 | HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS | PROCTER & GAMBLE (US) | 2024-02-08 | — | — | US | disclosed |
| US-11819474-B2 | Hair care compositions comprising malodor reduction materials | THE PROCTER & GAMBLE COMPANY (US) | 2023-11-21 | — | — | US | disclosed |
| EP-3197510-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197508-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197426-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| US-20170137753-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-05-18 | — | — | US | disclosed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016049397-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | PNMT 774/4885HSP90AA1 2278/4885CA1 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.